Advice

following an abbreviated submission:

clindamycin 1% / tretinoin 0.025% gel (Treclin®) is accepted for use within NHS Scotland.

Indication under review: for the topical treatment of acne vulgaris when comedones, papules and pustules are present in patients 12 years or older.

For use in patients for whom a topical combination of clindamycin and tretinoin is an appropriate choice of therapy.  This SMC advice takes account of the benefits of a Patient Access Scheme (PAS) that improves the cost-effectiveness of clindamycin 1% / tretinoin 0.025% gel.  This SMC advice is contingent upon the continuing availability of the patient access scheme in NHS Scotland or a list price that is equivalent or lower.
 

Download detailed advice74KB (PDF)

Download

Medicine details

Medicine name:
clindamycin 1% / tretinoin 0.025% gel (Treclin®)
SMC ID:
1010/14
Indication:
for the topical treatment of acne vulgaris when comedones, papules and pustules are present in patients 12 years or older.
Pharmaceutical company
Meda Pharmaceuticals Ltd
BNF chapter
Skin
Submission type
Abbreviated
Status
Accepted
Date advice published
08 December 2014